A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 28 Mar 2018 Status changed from active, no longer recruiting to completed.
- 19 Mar 2018 3 month follow-up results presented in the Aclaris Therapeutics media release.
- 11 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History